Methicillin-Resistant Staphylococcus aureus (MRSA): Resistance, Prevalence, and Coping Strategies
Antibiotics · 30.07.2025 · 14 (8) · 771
DOI: 10.3390/antibiotics14080771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 30.07.2025. Verfasst von Jiajing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Provincial Talent Project of Gansu Province; Science and Technology Plan Project of Gansu Province; the earmarked fund for CARS, Provincial Talent Project of Gansu Province, Science and Technology Plan Project of Gansu Province.
Abstract (Originalsprache)
Increased antimicrobial resistance requires effective ways to overcome the global challenge of bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA). From the emergence of MRSA to its continued evolution, it is important to explore this pathogen from fresh perspectives and develop corresponding coping strategies to counter its growing threat. New coping strategies are continuously emerging, including but not limited to enhancing penetration capabilities or targeting their virulence. This review summarizes the epidemiological characteristics, drug resistance mechanisms, and therapeutic strategies of MRSA that have emerged over the past fifteen years. The focus of this paper is to explore the promising applications and current limitations of novel MRSA control strategies. This review serves as a key resource for treating MRSA infections and discussing novel strategies to overcome bacterial drug resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.
- College of Life Science and Food Engineering, Hebei University of Engineering, Congtai District, Handan 056038, China.
- Key Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.
- Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs, Lanzhou 730050, China.
ORCID-Profile: Jiajing Li, Yubin Bai, Qing Wang
Förderung
- Provincial Talent Project of Gansu Province; Science and Technology Plan Project of Gansu Province; the earmarked fund for CARS
- Provincial Talent Project of Gansu Province
- Science and Technology Plan Project of Gansu Province
- earmarked fund for CARS
Zitieren
APA
Li, J., Cheng, F., Wei, X., Bai, Y., Wang, Q., Li, B., Zhou, Y., Zhai, B., Zhou, X., Wang, W., & Zhang, J. (2025). Methicillin-Resistant Staphylococcus aureus (MRSA): Resistance, Prevalence, and Coping Strategies. Antibiotics, 14(8), 771. https://doi.org/10.3390/antibiotics14080771
Vancouver
Li J, Cheng F, Wei X, Bai Y, Wang Q, Li B, et al. Methicillin-Resistant Staphylococcus aureus (MRSA): Resistance, Prevalence, and Coping Strategies. Antibiotics. 2025;14(8):771. doi:10.3390/antibiotics14080771
BibTeX
@article{Li2025,
author = {Li, Jiajing and Cheng, Fusheng and Wei, Xiaojuan and Bai, Yubin and Wang, Qing and Li, Bing and Zhou, Yaxin and Zhai, Bintao and Zhou, Xuzheng and Wang, Weiwei and Zhang, Jiyu},
title = {Methicillin-Resistant Staphylococcus aureus (MRSA): Resistance, Prevalence, and Coping Strategies},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {8},
pages = {771},
doi = {10.3390/antibiotics14080771}
}
EUVIMED